Business Description
Eurobio Scientific
ISIN : FR0013240934
Share Class Description:
FRA:E8TN: Bearer and/or Registered shares issued from reverse splitCompare
Compare
Traded in other countries / regions
ALERS.FranceE8TN.GermanyDXNHF.USA IPO Date
2020-04-07Description
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.88 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 3.96 | |||||
| Interest Coverage | 2.33 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.51 | |||||
| Beneish M-Score | -3.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.5 | |||||
| 3-Year EBITDA Growth Rate | -33.9 | |||||
| 3-Year EPS without NRI Growth Rate | -57 | |||||
| 3-Year FCF Growth Rate | -24.3 | |||||
| 3-Year Book Growth Rate | 22.4 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.76 | |||||
| 9-Day RSI | 41.75 | |||||
| 14-Day RSI | 40.38 | |||||
| 6-1 Month Momentum % | -3.62 | |||||
| 12-1 Month Momentum % | -8.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.32 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 102.33 | |||||
| Days Sales Outstanding | 77.62 | |||||
| Days Payable | 56.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 4 | |||||
| Shareholder Yield % | -25.15 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44 | |||||
| Operating Margin % | 7.76 | |||||
| Net Margin % | 3.7 | |||||
| FCF Margin % | 17.39 | |||||
| ROE % | 2.77 | |||||
| ROA % | 1.51 | |||||
| ROIC % | 3.13 | |||||
| ROC (Joel Greenblatt) % | 34.48 | |||||
| ROCE % | 4.22 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 30.92 | |||||
| PE Ratio without NRI | 25.93 | |||||
| Shiller PE Ratio | 17.4 | |||||
| Price-to-Owner-Earnings | 7.1 | |||||
| PEG Ratio | 0.57 | |||||
| PS Ratio | 1.14 | |||||
| PB Ratio | 0.85 | |||||
| Price-to-Tangible-Book | 6.59 | |||||
| Price-to-Free-Cash-Flow | 6.57 | |||||
| Price-to-Operating-Cash-Flow | 5.59 | |||||
| EV-to-EBIT | 14.11 | |||||
| EV-to-EBITDA | 6.25 | |||||
| EV-to-Revenue | 1.23 | |||||
| EV-to-FCF | 7.08 | |||||
| Price-to-Projected-FCF | 0.31 | |||||
| Price-to-Median-PS-Value | 1.18 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.12 | |||||
| Price-to-Graham-Number | 2.73 | |||||
| Price-to-Net-Current-Asset-Value | 52.96 | |||||
| Earnings Yield (Greenblatt) % | 7.09 | |||||
| FCF Yield % | 15.39 | |||||
| Forward Rate of Return (Yacktman) % | 38.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurobio Scientific Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 130.646 | ||
| EPS (TTM) (€) | 0.478 | ||
| Beta | 0.63 | ||
| Volatility % | 27.3 | ||
| 14-Day RSI | 40.38 | ||
| 14-Day ATR (€) | 0.194263 | ||
| 20-Day SMA (€) | 14.396 | ||
| 12-1 Month Momentum % | -8.19 | ||
| 52-Week Range (€) | 12.5 - 17.56 | ||
| Shares Outstanding (Mil) | 10.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurobio Scientific Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurobio Scientific Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eurobio Scientific Frequently Asked Questions
What is Eurobio Scientific(FRA:E8TN)'s stock price today?
The current price of FRA:E8TN is €14.30. The 52 week high of FRA:E8TN is €17.56 and 52 week low is €12.50.
When is next earnings date of Eurobio Scientific(FRA:E8TN)?
The next earnings date of Eurobio Scientific(FRA:E8TN) is .
Does Eurobio Scientific(FRA:E8TN) pay dividends? If so, how much?
Eurobio Scientific(FRA:E8TN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers